LAM IPM WOUND GEL RECEIVES REGULATORY APPROVAL FOR PANAMA

LAM Pharmaceutical, Corp. (OTC: LAMP; Frankfurt: LAM; Berlin: LAM), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that it received a regulatory approval to market and sell its patented and proprietary LAM IPM Wound Gel(TM) in the Republic of Panama. The approval was granted Ministerio de Salud, Direccion Nacional de Farmacia y Drogas (the Panamanian Ministry of Health), registration number "61523".

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-14-2005/0004107011&EDATE=)